FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma
FcεRIγ阴性NK细胞在体内持续存在,并增强治疗性单克隆抗体在多发性骨髓瘤中的疗效。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2020002440
Bigley, Austin B; Spade, Shanae; Agha, Nadia H; Biswas, Sujit; Tang, Suni; Malik, Muhammad H; Dai, Lu; Masoumi, Shalaleh; Patiño-Escobar, Bonell; Hale, Martina; DiPierro, Guy; Martell, Ronald; Hann, Byron; Shah, Nina; Wiita, Arun P; Liu, Xinli